QGEN Competitors & Alternatives
Compare Qiagen NV with similar stocks in the same industry
Diagnostics & Research
QGEN
Main Stock$41.40
Tradestie Score
52
Market Cap
$10.04B
P/E Ratio
21.3
Revenue Growth
0.0%
Analyst Upside
+6.4%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$112.52
|
$10.65B | 52.1 | 56 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.09
|
$9.33B | 102.9 | 50 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$232.51
|
$8.39B | - | 51 | Compare |
|
BIO
Bio-Rad Laboratories, Inc.Class A
|
$325.48
|
$8.06B | 54.4 | 54 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$161.99
|
$7.81B | - | 61 | Compare |
|
BLLN
BLLN
|
$138.60
|
$6.42B | 244.9 | 54 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$63.78
|
$6.00B | - | 49 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.86
|
$4.60B | 42.5 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$65.11
|
$3.26B | - | 63 | Compare |
More QGEN Analysis
Data updated: Aug 02, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry